Microscope peers into eczema skin changes during new drug treatment
NCT ID NCT07568665
First seen May 10, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study looks at how the skin of people with moderate-to-severe eczema changes when they are treated with tralokinumab. Researchers will use a special, non-invasive microscope to see the skin's structure in detail. The goal is to better understand how the treatment works on a cellular level. The study involves 15 adults who are already starting tralokinumab.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopitaux Drome NOrd
RECRUITINGRomans-sur-Isère, Drôme, 26100, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.